<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sucrose: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sucrose: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Sucrose: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_pediatric" data-topicid="16103" href="/d/html/16103.html" rel="external">see "Sucrose: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F13265422"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Sweet-Ease [OTC];</li>
<li>TootSweet [OTC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F13265425"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Analgesic, Nonopioid</li></ul></div>
<div class="block dop drugH1Div" id="F13266058"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="16103" href="/d/html/16103.html" rel="external">see "Sucrose: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="b7a4aaab-c30b-4ad2-9289-2072ced2582d">Analgesia/Comfort; minor procedures</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Analgesia (mild)/Comfort; minor procedures </b>
<b>(eg, heel sticks, immunizations, venipuncture, IV line insertion, arterial puncture, insertion of a Foley catheter, lumbar puncture): </b>Limited data available; optimal dose not established:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Oral: Usual dose: 2 mL of 24% solution administered 1 to 2 minutes before the start of the painful procedure; may be administered as 1 mL in each cheek or allow infant to suck solution from pacifier; effective range: 1 to 2 mL of 12% to 75% solution (AAP [Fein 2012]; Harrison 2010; Kassab 2012; Kassab 2020; Smith 2022). Based on data in preterm infants, some experts suggest that doses should be limited to &lt;10 doses/day (Harrison 2012; Johnston 2007).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51341001"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51341002"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F13265430"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Cardiovascular: Bradycardia (self-limiting)</p>
<p style="text-indent:-2em;margin-left:2em;">Hematologic &amp; oncologic: Oxygen desaturation (premature neonates; spontaneous resolution)</p>
<p style="text-indent:-2em;margin-left:2em;">Respiratory: Apnea (brief apnea in premature neonates; spontaneous resolution)</p></div>
<div class="block war drugH1Div" id="F13265428"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Gastrointestinal disorders: Patients should have a functioning gastrointestinal tract; avoid use in patients with gastrointestinal tract abnormalities (eg, esophageal atresia or tracheal esophageal fistula); while necrotizing enterocolitis (NEC) has not been reported with sucrose administration, risk:benefit assessment should be considered in patients at high risk for NEC.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Neonates: Efficacy in unstable or extremely low birth weight, premature neonates has not been established (LeFrak 2006).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Avoid use in patients at risk for aspiration; sucrose should not be used for patients requiring ongoing analgesia.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878696"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Use with caution in patients who are intubated to avoid gagging and choking; avoid use in paralyzed patients (LeFrak 2006).</p>
<p style="text-indent:-2em;margin-left:2em;">Concerns have been raised regarding repeated use of sucrose in patients &lt;31 weeks postconceptual age and neurodevelopmental and physical outcomes. In a randomized, double-blind, placebo-controlled trial, 103 neonates were randomized to receive sucrose (n=53) or sterile water at the beginning of minor procedures; repeat doses were given every 2 minutes for 3 doses or if procedure was longer than 15 minutes, 3 additional doses administered every 2 minutes were allowed. Patients receiving a higher number of sucrose doses had lower scores on motor development and vigor, and alertness and orientation components of the Neurobehavioral Assessment of the Preterm Infant (NAPI) at 36 weeks postconceptual age, lower motor development and vigor at 40 weeks postconceptual age, and higher Neuro-Biological Risk Score (NBRS) at 2 weeks postnatal age (Johnston 2002). The authors conducted a secondary analysis of the raw data and suggested neonates receiving &gt;10 doses of sucrose over a 24-hour period are at a higher risk of poorer neurodevelopmental outcomes (Johnston 2007).</p></div>
<div class="block foc drugH1Div" id="F13265444"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Solution, oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Sweet-Ease® Preserved: 24% (15 mL) </p>
<p style="text-indent:-2em;margin-left:4em;">TootSweet™: 24% (0.5 mL, 1 mL, 2 mL, 12 mL) </p>
<p style="text-indent:-2em;margin-left:2em;">Solution, oral [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;">Sweet-Ease Natural®: 24% (15 mL) </p></div>
<div class="block geq drugH1Div" id="F13265423"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block admp drugH1Div" id="F52614161"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: For oral use only; sucrose is ineffective when administered via nasogastric tube (Ramenghi 1999). May be administered directly onto tongue or buccal surface or via a pacifier dipped into solution. Analgesic effect is greater when used in conjunction with non-nutritive sucking and/or swaddling (AAP 2016). Dispose of product after use.</p></div>
<div class="block use drugH1Div" id="F13265426"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">Provide short-term analgesia in infants during immunization administration</p></div>
<div class="block pha drugH1Div" id="F13265436"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Exact mechanism is not known; it has been proposed that sucrose induces endogenous opioid release. </p></div>
<div class="block phk drugH1Div" id="F13265438"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset: Maximum effect: 2 minutes (Blass 1991)</p>
<p style="text-indent:-2em;margin-left:2em;">Duration: 3 to 5 minutes (Blass 1991)</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-26810788">
<a name="26810788"></a>American Academy of Pediatrics (AAP) Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine. Prevention and management of procedural pain in the neonate: an update. <i>Pediatrics</i>. 2016;137(2):e20154271. doi:10.1542/peds.2015-4271<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/26810788/pubmed" id="26810788" target="_blank">26810788</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1987534">
<a name="1987534"></a>Blass EM and Hoffmeyer LB, "Sucrose as an Analgesic for Newborn Infants," <i>Pediatrics</i>, 1991, 87(2):215-8.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/1987534/pubmed" id="1987534" target="_blank">1987534</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36824315">
<a name="36824315"></a>Bueno M, Ballantyne M, Campbell-Yeo M, et al. The effectiveness of repeated sucrose for procedural pain in neonates in a longitudinal observational study. <i>Front Pain Res (Lausanne)</i>. 2023;4:1110502. doi:10.3389/fpain.2023.1110502<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/36824315/pubmed" id="36824315" target="_blank">36824315</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Dandle Lion Kisses (sucrose) [prescribing information]. Danbury, CT: Dandle-LION Medical; February 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23109683">
<a name="23109683"></a>Fein JA, Zempsky WT, Cravero JP, Committee on Pediatric Emergency Medicine and Section on Anesthesiology and Pain Medicine, American Academy of Pediatrics. Relief of pain and anxiety in pediatric patients in emergency medical systems. <i>Pediatrics</i>. 2012;130(5):e1391-1405.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/23109683/pubmed" id="23109683" target="_blank">23109683</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23045554">
<a name="23045554"></a>Harrison D, Beggs S, Stevens B. Sucrose for procedural pain management in infants. <i>Pediatrics</i>. 2012;130(5):918-925. doi:10.1542/peds.2011-3848<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/23045554/pubmed" id="23045554" target="_blank">23045554</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20463370">
<a name="20463370"></a>Harrison D, Stevens B, Bueno M, et al, "Efficacy of Sweet Solutions for Analgesia in Infants Between 1 and 12 Months of Age: A Systematic Review," <i>Arch Dis Child</i>, 2010, 95(6):406-13.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/20463370/pubmed" id="20463370" target="_blank">20463370</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17200300">
<a name="17200300"></a>Johnston CC, Filion F, Snider L, et al. How much sucrose is too much sucrose? <i>Pediatrics</i>. 2007;119(1):226.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/17200300/pubmed" id="17200300" target="_blank">17200300</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12205254">
<a name="12205254"></a>Johnston CC, Filion F, Snider L, et al. Routine sucrose analgesia during the first week of life in neonates younger than 31 weeks' postconceptional age. <i>Pediatrics</i>. 2002;110(3):523-528.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/12205254/pubmed" id="12205254" target="_blank">12205254</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31870702">
<a name="31870702"></a>Kassab M, Almomani B, Nuseir K, Alhouary AA. Efficacy of sucrose in reducing pain during immunization among 10- to 18-month-old infants and young children: a randomized controlled trial. <i>J Pediatr Nurs</i>. 2020;50:e55-e61. doi:10.1016/j.pedn.2019.11.010<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/31870702/pubmed" id="31870702" target="_blank">31870702</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23235662">
<a name="23235662"></a>Kassab M, Foster JP, Foureur M, Fowler C. Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age. <i>Cochrane Database Syst Rev</i>. 2012;12:CD008411.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/23235662/pubmed" id="23235662" target="_blank">23235662</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30188590">
<a name="30188590"></a>Kristoffersen L, Malahleha M, Duze Z, et al. Randomised controlled trial showed that neonates received better pain relief from a higher dose of sucrose during venepuncture. <i>Acta Paediatr</i>. 2018;107(12):2071-2078. doi:10.1111/apa.14567<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/30188590/pubmed" id="30188590" target="_blank">30188590</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17079623">
<a name="17079623"></a>Lefrak L, Burch K, Caravantes R, et al. Sucrose analgesia: identifying potentially better practices. <i>Pediatrics</i>. 2006;118(suppl 2):S197-202.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/17079623/pubmed" id="17079623" target="_blank">17079623</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10325795">
<a name="10325795"></a>Ramenghi LA, Evans DJ, Levene MI. "Sucrose analgesia": absorptive mechanism or taste perception?. <i>Arch Dis Child Fetal Neonatal Ed</i>. 1999;80(2):F146-F147. doi:10.1136/fn.80.2.f146<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/10325795/pubmed" id="10325795" target="_blank">10325795</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35119438">
<a name="35119438"></a>Smith HAB, Besunder JB, Betters KA, et al. 2022 Society of Critical Care Medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility. <i>Pediatr Crit</i>
<i>Care Med</i>. 2022;23(2):e74-e110. doi:10.1097/PCC.0000000000002873<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/35119438/pubmed" id="35119438" target="_blank">35119438</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spruill.1">
<a name="Spruill.1"></a>Spruill CT, LaBrecque MA. Preventing and treating pain and stress among infants in the newborn intensive care unit. In: Eichenwald EC, Hansen AR, Martin CR, Stark AR, eds. <i>Cloherty and Stark's Manual of Neonatal Care</i>. 9th ed. Lippincott Williams &amp; Wilkins; 2022: chap. 70.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27420164">
<a name="27420164"></a>Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A. Sucrose for analgesia in newborn infants undergoing painful procedures. <i>Cochrane Database Syst Rev</i>. 2016;7(7):CD001069. doi:10.1002/14651858.CD001069.pub5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/27420164/pubmed" id="27420164" target="_blank">27420164</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29475433">
<a name="29475433"></a>Stevens B, Yamada J, Campbell-Yeo M, et al. The minimally effective dose of sucrose for procedural pain relief in neonates: a randomized controlled trial. <i>BMC Pediatr</i>. 2018;18(1):85.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/29475433/pubmed" id="29475433" target="_blank">29475433</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26583940">
<a name="26583940"></a>Thakkar P, Arora K, Goyal K, et al. To evaluate and compare the efficacy of combined sucrose and non-nutritive sucking for analgesia in newborns undergoing minor painful procedure: a randomized controlled trial. <i>J Perinatol</i>. 2016;36(1):67-70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/sucrose-drug-information/abstract-text/26583940/pubmed" id="26583940" target="_blank">26583940</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 17089 Version 46.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
